Publication date: February 2027 Source: American Heart Journal, Volume 304 Author(s): Matthew A. Cavender, Ania M. Jastreboff, Alice Y.Y. Cheng, Melanie J. Davies, Lucienne Donaldson, Lars-Ole Gerlach, Silas Hinsch Gylvin, Jacob Bonde Jacobsen, Nikolaus Marx, Cynthia Karenina Osorto Contreras, Carel W. le Roux, A. Michael Lincoff
Design and baseline characteristics of the CagriSema cardiovascular outcomes trial (REDEFINE 3). // American Journal of Kidney Diseases. – URL: https://www.sciencedirect.com/science/article/pii/S0002870326002887?dgcid=rss_sd_all
Design and baseline characteristics of the CagriSema cardiovascular outcomes trial (REDEFINE 3). American Journal of Kidney Diseases. https://www.sciencedirect.com/science/article/pii/S0002870326002887?dgcid=rss_sd_all
“Design and baseline characteristics of the CagriSema cardiovascular outcomes trial (REDEFINE 3).” American Journal of Kidney Diseases.
@article{article3254,
title = {Design and baseline characteristics of the CagriSema cardiovascular outcomes trial (REDEFINE 3)},
journal = {American Journal of Kidney Diseases},
url = {https://www.sciencedirect.com/science/article/pii/S0002870326002887?dgcid=rss_sd_all}
}